Literature DB >> 24338924

Extracellular Hsp90 mediates an NF-κB dependent inflammatory stromal program: implications for the prostate tumor microenvironment.

J E Bohonowych1, M W Hance, K D Nolan, M Defee, C H Parsons, J S Isaacs.   

Abstract

BACKGROUND: The tumor microenvironment (TME) plays an essential role in supporting and promoting tumor growth and progression. An inflammatory stroma is a widespread hallmark of the prostate TME, and prostate tumors are known to co-evolve with their reactive stroma. Cancer-associated fibroblasts (CAFs) within the reactive stroma play a salient role in secreting cytokines that contribute to this inflammatory TME. Although a number of inflammatory mediators have been identified, a clear understanding of key factors initiating the formation of reactive stroma is lacking.
METHODS: We explored whether tumor secreted extracellular Hsp90 alpha (eHsp90α) may initiate a reactive stroma. Prostate stromal fibroblasts (PrSFs) were exposed to exogenous Hsp90α protein, or to conditioned medium (CM) from eHsp90α-expressing prostate cancer cells, and evaluated for signaling, motility, and expression of prototypic reactive markers. In tandem, ELISA assays were utilized to characterize Hsp90α-mediated secreted factors.
RESULTS: We report that exposure of PrSFs to eHsp90 upregulates the transcription and protein secretion of IL-6 and IL-8, key inflammatory cytokines known to play a causative role in prostate cancer progression. Cytokine secretion was regulated in part via a MEK/ERK and NF-κB dependent pathway. Secreted eHsp90α also promoted the rapid and durable activation of the oncogenic inflammatory mediator signal transducer and activator of transcription (STAT3). Finally, eHsp90 induced the expression of MMP-3, a well-known mediator of fibrosis and the myofibroblast phenotype.
CONCLUSIONS: Our results provide compelling support for eHsp90α as a transducer of signaling events culminating in an inflammatory and reactive stroma, thereby conferring properties associated with prostate cancer progression.
© 2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  CAF; ERK; MMP; STAT3; prostate cancer

Mesh:

Substances:

Year:  2013        PMID: 24338924      PMCID: PMC4306584          DOI: 10.1002/pros.22761

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  65 in total

1.  Extracellular Hsp90 serves as a co-factor for MAPK activation and latent viral gene expression during de novo infection by KSHV.

Authors:  Zhiqiang Qin; Michael DeFee; Jennifer S Isaacs; Chris Parsons
Journal:  Virology       Date:  2010-05-06       Impact factor: 3.616

2.  Histone methyltransferase NSD2/MMSET mediates constitutive NF-κB signaling for cancer cell proliferation, survival, and tumor growth via a feed-forward loop.

Authors:  Ping Yang; Linlang Guo; Zhijian J Duan; Clifford G Tepper; Ling Xue; Xinbin Chen; Hsing-Jien Kung; Allen C Gao; June X Zou; Hong-Wu Chen
Journal:  Mol Cell Biol       Date:  2012-05-29       Impact factor: 4.272

3.  Interleukin-6 induces prostate cancer cell growth accompanied by activation of stat3 signaling pathway .

Authors:  W Lou; Z Ni; K Dyer; D J Tweardy; A C Gao
Journal:  Prostate       Date:  2000-02-15       Impact factor: 4.104

Review 4.  The reactive stroma microenvironment and prostate cancer progression.

Authors:  David A Barron; David R Rowley
Journal:  Endocr Relat Cancer       Date:  2012-10-30       Impact factor: 5.678

Review 5.  The R(h)oads to Stat3: Stat3 activation by the Rho GTPases.

Authors:  Leda Raptis; Rozanne Arulanandam; Mulu Geletu; James Turkson
Journal:  Exp Cell Res       Date:  2011-05-18       Impact factor: 3.905

Review 6.  Inflammation meets cancer, with NF-κB as the matchmaker.

Authors:  Yinon Ben-Neriah; Michael Karin
Journal:  Nat Immunol       Date:  2011-07-19       Impact factor: 25.606

7.  Reciprocal activation of prostate cancer cells and cancer-associated fibroblasts stimulates epithelial-mesenchymal transition and cancer stemness.

Authors:  Elisa Giannoni; Francesca Bianchini; Lorenzo Masieri; Sergio Serni; Eugenio Torre; Lido Calorini; Paola Chiarugi
Journal:  Cancer Res       Date:  2010-08-10       Impact factor: 12.701

8.  Reprint of: Stromogenic prostatic carcinoma pattern (carcinomas with reactive stromal grade 3) in needle biopsies predicts biochemical recurrence-free survival in patients after radical prostatectomy.

Authors:  Nobuyuki Yanagisawa; Rile Li; David Rowley; Hao Liu; Dov Kadmon; Brian J Miles; Thomas M Wheeler; Gustavo E Ayala
Journal:  Hum Pathol       Date:  2008-02       Impact factor: 3.466

9.  The hemopexin domain of MMP3 is responsible for mammary epithelial invasion and morphogenesis through extracellular interaction with HSP90β.

Authors:  Ana Luísa Correia; Hidetoshi Mori; Emily I Chen; Fernando C Schmitt; Mina J Bissell
Journal:  Genes Dev       Date:  2013-04-01       Impact factor: 11.361

10.  Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium.

Authors:  A F Olumi; G D Grossfeld; S W Hayward; P R Carroll; T D Tlsty; G R Cunha
Journal:  Cancer Res       Date:  1999-10-01       Impact factor: 12.701

View more
  35 in total

Review 1.  Regulation and function of the human HSP90AA1 gene.

Authors:  Abbey D Zuehlke; Kristin Beebe; Len Neckers; Thomas Prince
Journal:  Gene       Date:  2015-06-10       Impact factor: 3.688

2.  Grape Powder Supplementation Attenuates Prostate Neoplasia Associated with Pten Haploinsufficiency in Mice Fed High-Fat Diet.

Authors:  Tanvi Joshi; Ishani Patel; Avinash Kumar; Virginia Donovan; Anait S Levenson
Journal:  Mol Nutr Food Res       Date:  2020-07-12       Impact factor: 5.914

Review 3.  Epigenetic polypharmacology: A new frontier for epi-drug discovery.

Authors:  Daniela Tomaselli; Alessia Lucidi; Dante Rotili; Antonello Mai
Journal:  Med Res Rev       Date:  2019-06-20       Impact factor: 12.944

4.  Tumor-secreted Hsp90 subverts polycomb function to drive prostate tumor growth and invasion.

Authors:  Krystal D Nolan; Omar E Franco; Michael W Hance; Simon W Hayward; Jennifer S Isaacs
Journal:  J Biol Chem       Date:  2015-02-10       Impact factor: 5.157

5.  The Pharmacological Mechanism of Xiyanping Injection for the Treatment of Novel Coronavirus Pneumonia (COVID-19): Based on Network Pharmacology Strategy.

Authors:  Liang-Jing Xia; Liang-Ming Zhang; Kun Yang; Tong Chen; Xian-Wen Ye; Zi-Jun Yan
Journal:  Evid Based Complement Alternat Med       Date:  2022-07-08       Impact factor: 2.650

6.  Selective Inhibition of the Hsp90α Isoform.

Authors:  Sanket J Mishra; Anuj Khandelwal; Monimoy Banerjee; Maurie Balch; Shuxia Peng; Rachel E Davis; Taylor Merfeld; Vitumbiko Munthali; Junpeng Deng; Robert L Matts; Brian S J Blagg
Journal:  Angew Chem Int Ed Engl       Date:  2021-03-26       Impact factor: 15.336

Review 7.  Impact of Immunometabolism on Cancer Metastasis: A Focus on T Cells and Macrophages.

Authors:  Nina C Flerin; Sotiria Pinioti; Alessio Menga; Alessandra Castegna; Massimiliano Mazzone
Journal:  Cold Spring Harb Perspect Med       Date:  2020-09-01       Impact factor: 5.159

8.  NF-κB signaling pathway confers neuroblastoma cells migration and invasion ability via the regulation of CXCR4.

Authors:  Yunlai Zhi; Yuhe Duan; Xianjun Zhou; Xiaofeng Yin; Ge Guan; Hong Zhang; Qian Dong; Kun Yang
Journal:  Med Sci Monit       Date:  2014-12-21

9.  The double-edged sword: conserved functions of extracellular hsp90 in wound healing and cancer.

Authors:  Michael W Hance; Krystal D Nolan; Jennifer S Isaacs
Journal:  Cancers (Basel)       Date:  2014-05-06       Impact factor: 6.639

10.  The Multifaceted Roles of STAT3 Signaling in the Progression of Prostate Cancer.

Authors:  Jennifer L Bishop; Daksh Thaper; Amina Zoubeidi
Journal:  Cancers (Basel)       Date:  2014-04-09       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.